Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 231243, 7 pages
http://dx.doi.org/10.1155/2015/231243
Clinical Study

Site-Specific Immunomodulator: A Novel Treatment for Crohn’s Disease

1Gastrointestinal Research Institute (GIRI), Vancouver, BC, Canada V6Z 2K5
2Freeport Family Wellness Center, P.O. Box F41325, Freeport, Bahamas
3Institute for Immunotherapy and Integrative Oncology, 1130 Vienna, Austria
4Qu Biologics Inc., Vancouver, BC, Canada V5T 4T5
5Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA

Received 22 March 2015; Accepted 27 April 2015

Academic Editor: Antoni Castells

Copyright © 2015 Brian Bressler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Baumgart and W. J. Sandborn, “Crohn's disease,” The Lancet, vol. 380, no. 9853, pp. 1590–1605, 2012. View at Publisher · View at Google Scholar
  2. L. Peyrin-Biroulet, E. V. Loftus, J.-F. Colombel, and W. J. Sandborn, “The natural history of adult Crohn's disease in population-based cohorts,” The American Journal of Gastroenterology, vol. 105, no. 2, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Canavan, K. R. Abrams, and J. Mayberry, “Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease,” Alimentary Pharmacology & Therapeutics, vol. 23, no. 8, pp. 1097–1104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Hou, H. El-Serag, and S. Thirumurthi, “Distribution and manifestations of inflammatory bowel disease in asians, hispanics, and african americans: a systematic review,” The American Journal of Gastroenterology, vol. 104, no. 8, pp. 2100–2109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. B. Marks, F. Z. Rahman, G. W. Sewell, and A. W. Segal, “Crohn's disease: an immune deficiency state,” Clinical Reviews in Allergy & Immunology, vol. 38, no. 1, pp. 20–31, 2010. View at Publisher · View at Google Scholar
  6. G. W. Sewell, D. J. Marks, and A. W. Segal, “The immunopathogenesis of Crohn's disease: a three-stage model,” Current Opinion in Immunology, vol. 21, no. 5, pp. 506–513, 2009. View at Publisher · View at Google Scholar
  7. J. L. Casanova and L. Abel, “Revisiting Crohn's disease as a primary immunodeficiency of macrophages,” Journal of Experimental Medicine, vol. 206, no. 9, pp. 1839–1843, 2009. View at Publisher · View at Google Scholar
  8. A. M. Smith, F. Z. Rahman, B. Hayee et al., “Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease,” The Journal of Experimental Medicine, vol. 206, no. 9, pp. 1883–1897, 2009. View at Publisher · View at Google Scholar
  9. A. M. Smith, G. W. Sewell, A. P. Levine et al., “Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients,” Immunology, vol. 144, no. 1, pp. 45–55, 2015. View at Publisher · View at Google Scholar
  10. M. S. Silverberg, J. Satsangi, T. Ahmad et al., “Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology,” Canadian Journal of Gastroenterology, vol. 19, supplement A, pp. 5A–36A, 2005. View at Google Scholar
  11. K. Whitfield, K.-H. Huemer, D. Winter et al., “Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries,” Trials, vol. 11, article 104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. F. O. Martinez, S. Gordon, M. Locati, and A. Mantovani, “Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression,” The Journal of Immunology, vol. 177, no. 10, pp. 7303–7311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. Vinh and M. A. Behr, “Crohn's as an immune deficiency: from apparent paradox to evolving paradigm,” Expert Review of Clinical Immunology, vol. 9, no. 1, pp. 17–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Segal and G. Loewi, “Neutrophil dysfunction in Crohn’s disease,” The Lancet, vol. 308, no. 7979, pp. 219–221, 1976. View at Publisher · View at Google Scholar
  15. B. Hayee, F. Z. Rahman, G. Sewell, A. M. Smith, and A. W. Segal, “Crohn's disease as an immunodeficiency,” Expert Review of Clinical Immunology, vol. 6, no. 4, pp. 585–596, 2010. View at Publisher · View at Google Scholar
  16. D. J. B. Marks, M. W. N. Harbord, R. MacAllister et al., “Defective acute inflammation in Crohn's disease: a clinical investigation,” The Lancet, vol. 367, no. 9511, pp. 668–678, 2006. View at Publisher · View at Google Scholar
  17. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus